Partnership Targets Intraocular Biologics - Summary - MDSpire

Partnership Targets Intraocular Biologics

BioMed X and Boehringer launch new eye therapy research team

July 31, 2026
3 min

The Ophthalmologist

Share

Original Source(s)

The Ophthalmologist

Partnership Targets Intraocular Biologics

July 31, 2026

Related Content

British Journal Of Ophthalmology

Evaluation of the frequency, risk factors and outcomes of ROP in preterm infants with a BW >1500 g or GA >32 weeks in Turkiye (TR-ROP 2) and medicolegal fears: a Turkish Neonatal Society multicentre study

by Ahmet Yagmur Bas, Esin Koc, Sezin Unal, Ibrahim Murat Hirfanoglu
August 1, 2026

Frontiers In Medicine

Efficacy of intradermal acupuncture for ocular surface diseases secondary to refractory peripheral facial palsy: a randomized controlled trial study protocol

by Jiayi Yao, Lusha Cen, Qiushuang Li, Shan Liu, Chenjia Zhu, Lihua Xuan, Binyan Yu
July 20, 2026

Frontiers In Neurology

Longitudinal assessment of intraocular pressure in the 5xFAD mouse model of Alzheimer's disease

by Raz Rubinshtein, Basel Obied, Talal Salti, Andres I. König, Alon Zahavi, Nitza Goldenberg-Cohen
July 21, 2026